Analysis of clinical evidence for traditional Chinese medicines to treat corona virus disease 2019

doi:10.3877/cma.j.issn.1674-0785.2023.12.009

Abstract

Abstract:

Objective

To evaluate the efficacy and safety of 18 traditional Chinese medicines (TCMs) in the prevention and treatment of corona virus disease 2019 (COVID-19), in order to provide scientific evidence and guidance for clinical practitioners.

Methods

All the clinical studies related to TCM treatment of COVID-19 published as of March 16, 2023 were retrieved in six Chinese and English literature databases: PubMed, Embase, Cochrane Library, CNKI, Wanfang Data, and VIP Database. The basic characteristics, sample size, intervention measures, and main outcomes of studies on 18 TCMs were compared and analyzed, and the GRADE approach was used to assess the quality of evidence.

Results

Qingfei Paidu decoction, Lianhua Qingwen capsules (granules), Xuebijing injection, Shufeng Jiedu capsules, and other TCMs could effectively relieve the fever, cough, fatigue, and other symptoms of COVID-19 patients, shorten the hospitalization time and time to negative conversion of nucleic acid test result, increase the cure rate and recovery rate, reduce the rates of deterioration and mortality, improve pulmonary imaging manifestations, reduce inflammation level, and improve blood biochemical indicators and immune function indicators of the patients.

Conclusion

The 18 TCMs identified have obvious therapeutic effects and good safety for COVID-19.

Key words: Traditional Chinese medicine, Corona virus disease 2019, Clinical evidence

Shihao Ni, Xiaoming Dong, Haohui Liu, Xingling He, Donghua Liu, Ziru Li, Sijing Li, Yanhui Jiang, Jie Huang, Xiaojiao Zhang, Lu Lu, Zhongqi Yang. Analysis of clinical evidence for traditional Chinese medicines to treat corona virus disease 2019[J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(12): 1253-1269.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhlcyszz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-0785.2023.12.009

https://zhlcyszz.cma-cmc.com.cn/EN/Y2023/V17/I12/1253

References 60

1	中华人民共和国国家卫生健康委员会办公厅, 中华人民共和国国家中医药管理局办公室. 新型冠状病毒肺炎诊疗方案(试行第九版)[J]. 中国医药, 2022,17(4): 481-487.
2	中华人民共和国国家卫生健康委员会. 《新型冠状病毒感染诊疗方案(试行第十版)》[J]. 中国合理用药探索, 2023,20(1): 1-11.
3	Higgins JP, Altman DG, Gøtzsche PC, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials[J]. BMJ, 2011,343:d5928.
4	Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses[J]. Eur J Epidemiol, 2010,25(9):603-605.
5	Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations[J]. BMJ, 2008,336(7650):924-926.
6	余雪源, 张硕, 燕芳芳, 等. 采用清肺排毒汤联合西药43例与单用西药46例的新型冠状病毒肺炎临床疗效比较[J]. 山东大学学报(医学版), 2020,58(12): 47-53.
7	耿立梅, 郭登洲, 闫红倩,等. 回顾性分析河北省新型冠状病毒肺炎75例的临床特征及清肺排毒汤的临床疗效[J]. 河北中医,2022,44(6):918-922,948.
8	徐铁龙, 周旭, 陈晓凡,等. 江西省新型冠状病毒肺炎中医药实施与效果分析[J]. 江西中医药大学学报,2020,32(3):27-33.
9	曾宪红, 马文辉, 王洁. 清肺排毒汤对痰热壅肺型新冠肺炎患者临床疗效的影响[J]. 西部医学,2020,32(12):1799-1801,1806.
10	张平, 潘广涛. 清肺排毒汤改善新型冠状病毒肺炎危重型患者炎性细胞因子的临床研究[J]. 世界科学技术-中医药现代化,2021,23(2):391-395.
11	李旷宇, 安薇, 夏飞,等. 清肺排毒汤加减方联合抗病毒药物治疗新型冠状病毒肺炎的回顾性研究[J]. 中草药,2020,51(8):2046-2049.
12	王月, 陈立, 郑玲,等. 清肺排毒汤联合常规治疗对新冠肺炎患者的临床疗效[J]. 中成药,2021,43(3):656-659.
13	王巧琳, 孙龙飞, 赵明芬,等. 清肺排毒汤在新冠肺炎气阴两虚证患者恢复期治疗中的应用[J]. 中医学报,2021,36(5):910-914.
14	李亚冬, 张文静. 新冠肺炎中西医治疗方案临床效果评价[J]. 光明中医,2020,35(9):1273-1275.
15	施美, 侯勇, 周灏,等. 清肺排毒汤治疗47例新型冠状病毒肺炎的临床疗效观察[J]. 世界最新医学信息文摘,2021,21(40):223-224.
16	胡刚明, 贺朝雄, 孙秋凌,等. "清肺排毒颗粒"治疗新型冠状病毒肺炎的临床疗效初探[J]. 天津中医药,2020,37(9):999-1004.
17	孙宇洁, 许文彬, 马翠翠, 等. 基于三因制宜采用宣肺清热化湿法治疗皖北地区新型冠状病毒感染轻型、普通型临床观察[J]. 中医药临床杂志, 2023,35:1-10.
18	代卓青, 江四华, 刘田,等. 清肺排毒汤治疗36例新型冠状病毒肺炎的临床疗效分析[J]. 贵州中医药大学学报,2020,42(6):34-38.
19	孟军华, 何阳, 陈茜,等. 清肺排毒汤治疗普通型/重型新型冠状病毒肺炎的回顾性研究[J]. 中国医院药学杂志,2020,40(20):2152-2157.
20	王饶琼, 杨思进, 谢春光,等. 清肺排毒汤治疗新型冠状病毒肺炎的临床疗效观察[J]. 中药药理与临床,2020,36(1):13-18.
21	刘鹏, 韩萍. 中西医结合治疗非危重型新型冠状病毒肺炎的临床观察[J]. 中国民间疗法,2021,29(21):79-82.
22	王恩成, 唐琳, 徐奎, 等. 清肺排毒汤治疗75例新型冠状病毒肺炎轻型与普通型酶学指标改善的疗效评价[J]. 中药与临床, 2020,11(1): 3-5.
23	李婵. 雷火灸联合清肺排毒汤治疗临床症状符合小儿寒湿闭肺证新型冠状病毒肺炎的临床疗效[J]. 临床合理用药杂志,2022,15(4):32-35.
24	余恒毅, 任秀华, 祁星星, 等. 阿比多尔、清肺排毒汤、连花清瘟胶囊、金叶败毒颗粒对某方舱医院轻型/普通型新冠肺炎患者疗效的回顾性研究[J]. 中药药理与临床, 2020,36(6): 2-6.
25	汪升早, 王华军, 陈鸿明,等. 连花清瘟胶囊和α-干扰素联合洛匹那韦/利托那韦治疗新型冠状病毒肺炎30例[J]. 蚌埠医学院学报,2020,45(2):154-155.
26	谭杜勋, 石文磊, 刘楠,等. 连花清瘟胶囊在新冠肺炎中早期抗病毒、抗炎的疗效观察[J]. 中国处方药,2021,19(5):92-93.
27	余平, 李叶子, 万少兵,等. 连花清瘟颗粒联合阿比多尔治疗轻度新型冠状病毒肺炎的疗效观察[J]. 中国药学杂志,2020,55(12):1042-1045.
28	Hu K, Guan WJ, Bi Y, et al. Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trial[J]. Phytomedicine, 2021,85:153242.
29	夏一淼, 王法财, 沈炳香,等. 连花清瘟颗粒联合洛匹那韦/利托那韦治疗新型冠状病毒肺炎的疗效与安全性回顾性研究[J]. 中国医院用药评价与分析,2021,21(2):179-181,184.
30	Shen P, Li J, Tu S, et al. Positive effects of Lianhuaqingwen granules in COVID-19 patients: a retrospective study of 248 cases[J]. J Ethnopharmacol, 2021,278:114220.
31	陈超武, 李晓良, 刘亚峰,等. 连花清瘟胶囊治疗新型冠状病毒肺炎临床研究[J]. 中西医结合研究,2021,13(1):1-4.
32	陈灵, 柳芳, 夏杨,等. 20例新型冠状病毒肺炎患者临床特点及中西医结合治疗全过程的回顾性分析[J]. 中国医院用药评价与分析,2020,20(9):1030-1037.
33	李硕, 陆伟, 赵学群,等. 不同剂量血必净注射液治疗重型新型冠状病毒肺炎的疗效观察[J]. 中国中西医结合急救杂志,2020,27(3):267-270.
34	李建洪, 庞永诚, 杨滨枚,等. 血必净注射液治疗新型冠状病毒肺炎疑似病例24例临床研究[J]. 湖南中医杂志,2022,38(1):11-13.
35	刘学松, 宋元林, 关伟杰,等. 血必净注射液治疗重症新型冠状病毒肺炎的多中心前瞻性队列研究[J]. 中华危重病急救医学,2021,33(7):774-778.
36	刘凯凤, 付敏, 张郑平, 等. 血必净对2019新型冠状肺炎患者的临床疗效[C]. 北京: 全国科研理论学术研究大会, 2020.
37	陈灵, 柳芳, 吴金虎, 等. 回顾性分析疏风解毒胶囊联合西医治疗普通型新型冠状病毒肺炎患者的临床疗效[J]. 中国实验方剂学杂志, 2020,26(16): 14-20.
38	瞿香坤, 郝树立, 马景贺, 等. 疏风解毒胶囊联合阿比多尔治疗新型冠状病毒肺炎的回顾性研究[J]. 中草药, 2020,51(5): 1167-1170.
39	瞿香坤, 唐超, 郝树立,等. 疏风解毒胶囊联合阿比多尔治疗新型冠状病毒肺炎临床疗效观察[J]. 中国处方药,2021,19(3):6-8.
40	肖琦, 蒋茵婕, 吴思思, 等. 中药疏风解毒胶囊联合阿比多尔治疗轻症新型冠状病毒肺炎的价值分析[J]. 中国中医急症, 2020,29(5): 756-758.
41	颜成果, 闪海霞, 裴旭东, 等. 疏风解毒胶囊联合α-干扰素和阿比多尔治疗普通型新型冠状病毒肺炎的疗效和安全性分析[J]. 广州中医药大学学报, 2022,39(3): 475-480.
42	张佳莹, 李丽, 汪晓军, 等. 金花清感颗粒治疗成例新型冠状病毒肺炎患者的多中心前瞻性队列研究[J]. 北京医学, 2021,43(9): 866-870.
43	段璨, 夏文广, 郑婵娟,等. 金花清感颗粒联合西医常规治疗方案治疗轻型新型冠状病毒肺炎的临床观察[J]. 中医杂志,2020,61(17):1473-1477.
44	刘清泉, 励国, 张杰,等. 苏合香丸治疗新型冠状病毒感染患者的临床观察[J]. 中草药,2023,54(4):1201-1207.
45	陈伟焘, 袁天慧, 詹少锋,等. 痰热清注射液治疗新型冠状病毒感染肺炎真实世界临床研究报告[J]. 广州中医药大学学报,2022,39(3):463-468.
46	冯利民, 刘晓亚, 张磊. 宣肺败毒颗粒治疗新型冠状病毒肺炎(奥密克戎)的临床疗效观察[J]. 天津中医药,2022,39(5):545-550.
47	李旭成, 张军, 夏文广,等. 宣肺败毒汤治疗重症新型冠状病毒肺炎的临床病例观察[J]. 中国中药杂志,2022,47(13):3667-3674.
48	Shi N, Guo L, Liu B, et al. Efficacy and safety of Chinese herbal medicine versus Lopinavir-Ritonavir in adult patients with coronavirus disease 2019: A non-randomized controlled trial[J]. Phytomedicine, 2021,81:153367.
49	童欢, 许鑫, 陈汉华. 化湿败毒方联合西医治疗重型新型冠状病毒肺炎23例[J]. 亚太传统医药,2022,18(3):75-79.
50	杨焕彪, 李耀新, 曹理铭,等. 藿香正气散加减配合西医治疗新型冠状病毒肺炎11例[J]. 广西中医药,2020,43(3):1-4.
51	秦娅蓝, 宋玉燕, 周璐,等. 热毒宁联合甲泼尼龙治疗重症新型冠状病毒肺炎临床疗效评价[J]. 中国药业,2020,29(9):19-22.
52	Xu X, Zhang J, Zheng W, et al. Efficacy and safety of Reduning injection in the treatment of COVID-19: a randomized, multicenter clinical study[J]. Ann Palliat Med, 2021,10(5):5146-5155.
53	杨明博, 党双锁, 黄胜,等. 热炎宁合剂治疗新型冠状病毒肺炎的多中心临床观察[J]. 中国实验方剂学杂志,2020,26(14):7-12.
54	胡芬, 郭爱华, 黄鹿,等. 不同剂量金银花口服液联合西医常规疗法治疗新型冠状病毒肺炎普通型187例多中心临床观察[J]. 中医杂志,2021,62(6):510-515.
55	张又莉, 雷亮, 徐勇,等. 金银花口服液治疗新型冠状病毒肺炎80例临床疗效分析[J]. 中国药业,2020,29(9):23-26.
56	陈旋, 张炜, 孙萌,等. 宣肺止嗽合剂治疗新型冠状病毒感染咳嗽有效性及安全性的临床研究[J]. 中华中医药学刊,2023,41(4):9-12.
57	宋欠红, 柳尧, 朱虹江,等. 化湿解毒方治疗新型冠状病毒肺炎湿热郁肺证的临床研究[J]. 云南中医中药杂志,2021,42(2):23-27.
58	赵张燕, 颜萱, 徐萍,等. 清咳平喘颗粒治疗轻型、普通型新型冠状病毒感染的临床研究[J]. 现代药物与临床,2023,38(2):437-441.
59	Chen Y, Liu C, Wang T, et al. Efficacy and safety of Bufei Huoxue capsules in the management of convalescent patients with COVID-19 infection: A multicentre, double-blind, and randomised controlled trial[J]. J Ethnopharmacol, 2022,284:114830.
60	吴瑞, 王朝亮, 焦常新,等. 三拗鱼龙合剂治疗新冠肺炎疗效观察[J]. 中医药临床杂志,2021,33(7):1368-1371.

[1]	Xining Wu, Yunshu Ouyang, Hua Meng, Yuxin Jiang, Yixiu Zhang, Qing Dai, Zhonghui Xu, Jianchu Li. Comparative analysis of obstetric ultrasound workload in Peking Union Medical College Hospital during Corona Virus Disease 2019 epidemic [J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2022, 19(09): 990-993.
[2]	Hongxing Chen, Lijun Zhang, Yong Zhang, Hu Li, Chi Zhou, Yinuo Fan. Meta-analysis of effect of external application of traditional Chinese medicine after arthroscopic debridement in knee osteoarthritis [J]. Chinese Journal of Joint Surgery(Electronic Edition), 2023, 17(05): 663-672.
[3]	Wei Yang, Xia Hao, Dongzhen Zhu, Jinbo Zhang, Xuefei Tian, Bin Yao. A meta analysis of the clinical effect of traditional Chinese medicine on burn and scald patients [J]. Chinese Journal of Injury Repair and Wound Healing(Electronic Edition), 2023, 18(05): 419-426.
[4]	Anqi Li, Yilin Xu, Tianxin Xiang. Progress on diagnosis and treatment of post corona virus disease 2019 pulmonary fibrosis [J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2023, 17(05): 294-298.
[5]	Mingchao Zhu, Ya Zhu, Feibo Guo, Yine Huang. Influence on blood routine parameters of severe acute respiratory syndrome coronavirus 2 infection induced cold condensation aggregation [J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2023, 17(04): 244-251.
[6]	Zhenhua Li, Baojiang Xie, Wei Yi, Li Li, Yaxian Wei, Mingshu Zhou, Nuo Yi. Psychological intervention on cognition of pregnant women on epidemic prevention and control during the period of corona virus disease 2019 and the key points of normalizing countermeasures [J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2023, 17(03): 173-179.
[7]	Yue Liao, Ke Wang, Jiangyue Qin, Yanqiu Wu, Jun Chen, Tao Wang, Fuqiang Wen, Hao Wang. Efficacy of Danlong oral liquid in treatment of mild-to-moderate acute exacerbation of chronic obstructive pulmonary disease: A multicenter, prospective, observational cohort study [J]. Chinese Journal of Lung Diseases(Electronic Edition), 2023, 16(03): 306-311.
[8]	Junqiao Shao, Ming Wang. Treatment of sleep disorders in maintenance hemodialysis patients with traditional Chinese medicine [J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2023, 12(02): 97-100.
[9]	Siqi Yang, Tianmeng Wang, Yaoguang Wang. Clinical efficacy and safety of Huobahuagen tablets combined with Yishen Xiaozhuo formula in treating chronic glomerulonephritis with spleen-kidney qi deficiency and damp turbidity syndrome [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(12): 1241-1246.
[10]	Sugui Wang, Liyuan Huang, Fujin Jiang, Ziyu Wu, Xianyun Zhang, Qiang Li, Dali Yan. Role of HNRNPA2B1 in prostate cancer and screening of HNRNPA2B1-targeted active components of traditional Chinese medicine [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(06): 731-736.
[11]	Guangjie Liu, Guanglin Wang, Shaoqing Fan, Guiying Wang. Causes and counter measures of negative emotion and behavior associated with local COVID-19 epidemic in cancer patients [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(01): 93-96.
[12]	Chunguo Xing, Yingqiu Xia, Yunxia Liao, Ning Zhao, Ran Tao. Informatization construction of public health in primary medical institutions in Jiangsu Province [J]. Chinese Journal of Clinicians(Electronic Edition), 2022, 16(12): 1201-1206.
[13]	Anna Jing, Bo Li, Yuzhen Wu, Ying Cui, Yuping Ma, Yuxian Li, Shiyi Jiang, Yutong Zhou. A study on the indications of Xingnao Kaiqiao acupuncture based on clinical evidence [J]. Chinese Journal of Acupuncture and Moxibustion(Electronic Edition), 2023, 12(04): 167-172.
[14]	Youtao Ge, Qiuzi Jiang, Tingsong Bian, Qianqian Xiao. Study on the law of formation and molecular mechanism of traditional Chinese medicine in treating late-onset hypogonadism in male [J]. Chinese Journal of Geriatrics Research(Electronic Edition), 2023, 10(03): 43-50.
[15]	Zhiwei Xu, Huihua Liu, Weizhao Qin, Guiyu Feng, Xian Li, Cui Qin, Jiejie Lin, Guohui. Liang. Clinical efficacy of Qizhidan Tongluo capsule in treating qi deficiency and blood stasis syndrome of non-acute ischemic stroke [J]. Chinese Journal of Cerebrovascular Diseases(Electronic Edition), 2023, 17(03): 232-236.

Please choose a citation manager

Content to export